International safety notice
Corrective Action for primary antibodies to CD2 and CD7, Leica Biosystems
Germany / BfArM · DEU · Feb 17, 2012
Key facts
| Title | Corrective Action for primary antibodies to CD2 and CD7, Leica Biosystems |
|---|---|
| Regulator | Germany / BfArM |
| Country | DEU |
| Brand | primary antibodies to CD2 and CD7, Leica Biosystems |
| Manufacturer | Corrective Action for primary antibodies to CD2 and CD7, Leica Biosystems |
| Models | 191-215-1152, 158019, 08173, 10604, PA0266, 1158020, CLONE14F14, 11F11, PA0271, —215—1152, L158018, NCL-L-CD7-580 and 7 more |
| Date | Feb 17, 2012 |
| Regulator page | bfarm.de |
At a glance
- No Recall
- No Field safety notice
- 10–99 Matching device models in FDA data
- 10–99 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1